Acute Lymphocytic Leukemia (ALL)
9 clinical trials · Condition
◉ Watch Acute Lymphocytic Leukemia (ALL)
| Record | Firm | Date |
|---|---|---|
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases (NCT01962636) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| Red Cell Transfusion Goals in Patients With Acute Leukemias (NCT02086773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Study of the Glutaminase Inhibitor CB-839 in Leukemia (NCT02071927) | Calithera Biosciences, Inc | 2014-03-01 |
| Unrelated Umbilical Cord Blood (UBC)Transplantation (NCT01768845) | West Virginia University | 2009-02-03 |
| Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia (NCT00664677) | Erimos Pharmaceuticals | 2007-08-01 |
| Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant (NCT00088543) | Genzyme, a Sanofi Company | 2004-03-01 |
| Expanded Access to Navitoclax (NCT03592576) | AbbVie |
Track Acute Lymphocytic Leukemia (ALL) automatically
Every clearance here is in the API, with alerts when new ones post.